IX

ORIX
D

IX

Arincen57/100B
32.600
USD
-1.56
(-4.57%)
Market Open
Last updated: · Delayed 15 min

ORIX net income 1998–2027

ORIX earned 575.39B JPY in Q2 FY2027, the three months to 30 September 2026, up 251.3% on the same quarter a year before. ORIX's net income over the last twelve months was 1.03T JPY, up 135.0% on the twelve months before. In fiscal year 2026 it earned 475.04B JPY, up 35.1% on the year before.

Last updated 10 Nov 2026 · Next report 8 Feb 2027

Net income

Net income · +6.2% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 20261.03T+134.99%33.18%3.11T
FY202631 Mar 2026475.04B+35.10%13.45%3.53T
FY202531 Mar 2025351.63B+1.59%12.23%2.87T
FY202431 Mar 2024346.13B+19.22%12.30%2.81T
FY202331 Mar 2023290.34B-8.52%10.90%2.66T
FY202231 Mar 2022317.38B+64.97%12.65%2.51T
FY202131 Mar 2021192.38B-36.44%8.39%2.29T
FY202031 Mar 2020302.70B-6.50%13.27%2.28T
FY201931 Mar 2019323.75B+3.39%13.34%2.43T
FY201831 Mar 2018313.14B+14.60%10.94%2.86T
FY201731 Mar 2017273.24B+5.02%10.20%2.68T
FY201631 Mar 2016260.17B+10.73%10.98%2.37T
FY201531 Mar 2015234.95B+25.40%10.81%2.17T
FY201431 Mar 2014187.36B+67.68%13.65%1.37T
FY201331 Mar 2013111.74B+33.81%10.62%1.05T
FY201231 Mar 201283.51B+26.49%10.62%786.21B
FY201131 Mar 201166.02B+74.86%7.80%846.61B
FY201031 Mar 201037.76B+72.22%4.55%830.27B
FY200931 Mar 200921.92B-86.94%2.31%947.96B
FY200831 Mar 2008167.91B-14.40%15.22%1.10T
FY200731 Mar 2007196.17B+17.70%17.95%1.09T
FY200631 Mar 2006166.67B+82.42%18.08%922.08B
FY200531 Mar 200591.36B+69.18%11.21%814.87B
FY200431 Mar 200454.00B+81.65%7.98%676.92B
FY200331 Mar 200329.73B-25.93%4.89%608.39B
FY200231 Mar 200240.14B+15.32%7.08%566.73B
FY200131 Mar 200134.81B+17.34%7.14%487.54B
FY200031 Mar 200029.66B+15.15%6.12%484.62B
FY199931 Mar 199925.76B+8.55%5.70%451.88B
FY199831 Mar 199823.73B—28.83%82.32B

Figures in JPY. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about ORIX's profit

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.